HEAD NECK CANCER
Clinical trials for HEAD NECK CANCER explained in plain language.
Never miss a new study
Get alerted when new HEAD NECK CANCER trials appear
Sign up with your email to follow new studies for HEAD NECK CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo offers hope for head and neck cancer patients who Can't take standard treatment
Disease control OngoingThis study tests a weekly combination of chemotherapy (carboplatin and paclitaxel) plus immunotherapy (pembrolizumab) in 31 adults with advanced head and neck cancer that has spread. It is for patients who cannot take the standard drug 5-fluorouracil. The goal is to see if this r…
Matched conditions: HEAD NECK CANCER
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 16, 2026 23:23 UTC
-
New drug combo targets tough cancers in early trial
Disease control TerminatedThis early-phase study tests a combination of two drugs, palbociclib and gedatolisib, in people with advanced lung, pancreatic, head & neck, or other solid tumors that have not responded to standard treatments. The main goals are to find the safest dose and to check for side effe…
Matched conditions: HEAD NECK CANCER
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 16, 2026 12:52 UTC
-
Radiation's hidden toll on teeth revealed in new study
Knowledge-focused OngoingThis study follows 100 head and neck cancer patients receiving standard radiotherapy to see how their teeth, gums, and saliva change over time. Researchers measure gum health, tooth condition, and quality of life before and after treatment. The goal is to better understand long-t…
Matched conditions: HEAD NECK CANCER
Sponsor: Ain Shams University • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:25 UTC